Acute demyelinating encephalomyelitis in a child with pulmonary tuberculosis.
Jasmine SinghPallavi SharmaShivani RandevNarinder KaurPankaj KumarVishal GuglaniPublished in: Paediatrics and international child health (2024)
Tuberculosis is a leading cause of mortality in children worldwide. One of the greatest challenges in its management is the difficulty of diagnosis as the manifestations are non-specific and often mimic other illnesses. Neurological infection occurs in approximately 1% of patients diagnosed with tuberculosis, and usually takes the form of tuberculous meningitis or tuberculoma. An 11-year-old girl who was diagnosed with acute disseminated encephalomyelitis, a rare immunological manifestation of tuberculosis, is presented. She recovered completely after a course of high-dose systemic corticosteroids in addition to anti-tuberculosis treatment. Considering the immense burden of this infectious disease, recognition and understanding of the uncommon manifestations are important to enable appropriate and timely treatment. Abbreviations: ADEM: acute disseminated encephalomyelitis; ATT: anti-tuberculosis therapy; CBNAAT: cartridge-based nucleic acid amplification test; CNS: central nervous system; CSF: cerebrospinal fluid; CT: computed tomography; FLAIR: fluid attenuated inversion recovery; IFN: interferon; MRI: magnetic resonance imaging; MTB: Mycobacterium tuberculosis ; TB: tuberculosis; TNF: tumour necrosis factor.
Keyphrases
- mycobacterium tuberculosis
- pulmonary tuberculosis
- magnetic resonance imaging
- computed tomography
- cerebrospinal fluid
- contrast enhanced
- nucleic acid
- liver failure
- high dose
- respiratory failure
- dendritic cells
- drug induced
- end stage renal disease
- infectious diseases
- hiv aids
- chronic kidney disease
- mental health
- risk factors
- intensive care unit
- young adults
- low dose
- magnetic resonance
- positron emission tomography
- stem cells
- dual energy
- immune response
- type diabetes
- acute respiratory distress syndrome
- label free
- antiretroviral therapy
- bone marrow
- brain injury
- patient reported